AlbertA. (1966). The acridines, 2nd edition. London: Edward Arnold Ltd.
3.
ArmstrongJ. A.NivenJ. S. F. (1957). Fluorescence microscopy in the study of nucleic acids. Nature (Lond), 180, 1335.
4.
BrowningC. H. (1908). Chemotherapy in experimental trypanosome infections. J. Path. Bact., 12, 166.
5.
BrowningC. H. (1937). Chemotherapeutic antiseptics. Edinb. med. J., 44, 497.
6.
BrowningC. H. (1944). Problems of infection. Glasg. med. J., 141, 1.
7.
BrowningC. H. (1964). Chemotherapy with antibacterial dye stuffs. In Experimental chemotherapy, Edited by SchnitzerR. J.HawkingF., 2, 1. London and New York: Academic Press.
8.
BrowningC. H.CalverK. M. (1943). Effect of stage of infection on chemotherapeutic response of T. congolense and immunity following cure. J. Path. Bact., 55, 393.
9.
BrowningC. H.GilmourW. (1913). Bactericidal action and chemical constitution of basic benzol derivatives. J. Path. Bact., 18, 144.
10.
BrowningC. H.GulbransenR. (1922). Interference phenomenon in the action of chemotherapeutic substances in experimental trypanosome infections. J. Path. Bact., 25, 395.
11.
BrowningC. H.GulbransenR. (1927). Interference phenomenon in the action of chemotherapeutic substances in experimental trypanosome infections. J. Path. Bact., 30, 513.
12.
BrowningC. H.BrowningP.RobbJ. V. M. (1940). Phenanthridinium compound of Morgan and Walls as a chemotherapeutic agent in experimental infections with T. congolense. J. Path. Bact., 50, 371.
13.
BrowningC. H.CruickshankJ.MackenzieI. (1910). Constituents of the Wassermann reaction, especially lecithin and cholesterin. J. Path. Bact., 14, 484.
14.
BrowningC. H.GulbransenR.NivenJ. S. F. (1936). Sarcoma production in mice by a single subcutaneous injection of a benzoyl amino quinoline styryl compound. J. Path. Bact., 42, 155.
15.
BrowningC. H.GulbransenR.ThorntonL. H. D. (1917). Antiseptic properties of acriflavine, proflavine, etc. Brit. med. J., 2, 70.
16.
BrowningC. H.CohenJ. B.CooperE. E.GulbransenR. (1931). Therapeutic interference caused by isomerides of trypanocidal styryl quinoline derivatives. Proc. roy. Soc. B., 109, 51.
17.
BrowningC. H.GulbransenR.KennawayE. L.ThorntonL. H. D. (1917). Flavine etc.; their use in the treatment of infected wounds. Brit. med. J., 1, 73.
18.
BrowningC. H.MorganG. T.RobbJ. V. M.WallsL. P. (1938). Trypanocidal action of certain phenanthridinium compounds. J. Path. Bact., 46, 203.
19.
GarrodL. P. (1955). Chemicals versus bacteria. Proc. roy. Soc. Med., 48, 21.
20.
GordonJ.McLeodJ. W.Mayr-HartingA.OrrJ. W.ZinnemannK. W. (1947). The value of antiseptics as prophylactic applications to recent wounds. J. Hyg., 45, 297.
21.
HawkingF. (1963). Chemotherapy of trypanosomiasis. In Experimental chemotherapy, Edited by SchnitzerR. J.HawkingF., 1 [5, Part 2 vi.] London and New York: Academic Press.
22.
LederbergJ. (1955). Genetics and microbiology. Chapter 3 in Perspectives and horizons in microbiology, Edited by WaxmanS. A.. New Brunswick, N.J.: Rutgers University Press.
23.
LourieE. M. (1945). Abstract of unpublished thesis for the degree of Ph.D. by K. M. Calver, Chemotherapeutic studies on experimental T. congolense infections. Trop. Dis. Bull., 42, 704.
24.
NivenJ. S. F.McCluskieJ. A. W. (1934). Examination of the sarcoma-producing benzoyl amino styryl compound 'styryl-430′ and related substances for oestrogenic action. J. Path. Bact., 39, 185.
25.
WaddingtonC. H. (1938). Studies on the nature of the amphibian organisation centre. Proc. roy. Soc. B., 125, 365.